Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an inherited enzymatic disorder associated with severe neonatal hyperbilirubinemia and acute haemolysis after exposure to certain drugs or infections. The disorder can be diagnosed phenotypically with a fluorescent spot test (FST), which is a simple test that requires training and basic laboratory equipment. This study aimed to assess the diagnostic performances of the FST used on umbilical cord blood by locally-trained staff and to compare test results of the neonates at birth with the results after one month of age. Methods : We conducted a cohort study on newborns at the Shoklo Malaria Research Unit, along the Thai-Myanmar border between January 2015 and May 2016. The FST was performed at birth on the umbilical cord blood by locally-trained staff and quality controlled by specialised technicians at the central laboratory. The FST was repeated after one month of age. Genotyping for common local G6PD mutations was carried out for all discrepant results. Results: FST was performed on 1521 umbilical cord blood samples. Quality control and genotyping revealed 10 misdiagnoses. After quality control, 10.7% of the males (84/786) and 1.2% of the females (9/735) were phenotypically G6PD deficient at birth. The FST repeated at one month of age or later diagnosed 8 additional G6PD deficient infants who were phenotypically normal at birth. Conclusions : This study shows the short-comings of the G6PD FST in neonatal routine screening and highlights the importance of training and quality control. A more conservative interpretation of the FST in male newborns could increase the diagnostic performances. Quantitative point-of-care tests might show higher sensitivity and specificity for diagnosis of G6PD deficiency on umbilical cord blood and should be investigated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“testing for G6PD deficiency on umbilical cord blood or very early in the neonatal period using qualitative rapid tests has been shown to be unreliable [23] because of reticulocytosis [24].”
From Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood (2018) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose-6-phosphate dehydrogenase deficiency
Cappellini, M., & Fiorelli, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60073-2 · Cited by 1,590
Current status of newborn screening worldwide: 2015
Therrell, B. L., Padilla, C. D., Loeber, J. G., Kneisser, I., Saadallah, A., Borrajo, G. J. C., & Adams, J. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.03.002 · Cited by 602
Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border
Bancone, G., Chu, C. S., Somsakchaicharoen, R., Chowwiwat, N., Parker, D. M., Charunwatthana, P., White, N. J., & Nosten, F. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116063 · Cited by 99
Self-citationNeonatal Intensive Care in a Karen Refugee Camp: A 4 Year Descriptive Study
Turner, C., Carrara, V., Aye Mya Thein, N., Chit Mo Mo Win, N., Turner, P., Bancone, G., White, N. J., McGready, R., & Nosten, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072721 · Cited by 52
Self-citationEarly Neonatal Bilirubin, Hematocrit, and Glucose-6-Phosphate Dehydrogenase Status
Badejoko, B. O., Owa, J. A., Oseni, S. B. A., Badejoko, O., Fatusi, A. O., & Adejuyigbe, E. A. (2014) · Pediatrics · doi:10.1542/peds.2014-0654 · Cited by 24
Research works printed but not linked: 31
- R Howes, 2012, G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map., PLoS Med., 9, e1001339, 10.1371/journal.pmed.1001339 · DOI · Paper page
- Z Rostami-Far, 2016, Glucose-6-phosphate dehydrogenase deficiency (G6PD) as a risk factor of male neonatal sepsis., J Med Life., 9, 34-8
- J Watchko, 2013, Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?, J Perinatol., 33, 499-504, 10.1038/jp.2013.14 · DOI
- M Maisels, 2009, Hyperbilirubinemia in the newborn infant > or =35 weeks’ gestation: an update with clarifications., Pediatrics., 124, 1193-8, 10.1542/peds.2009-0329 · DOI · Paper page
- M Kaplan, 1999, Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes., Pediatrics., 104, 68-74, 10.1542/peds.104.1.68 · doi:10.1542/peds.104.1.68
- Y Arain, 2014, Prevention of kernicterus in South Asia: Role of neonatal G6PD deficiency and its identification., Indian J Pediatr., 81, 599-607, 10.1007/s12098-014-1410-y · DOI
- 1989, Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group., Bull World Health Organ., 67, 601-11
- E Beutler, 2015, Special Modifications of the Fluorescent screening method for Glucose-6-Phosphate Dehydrogenase Deficiency., Fluoresc Screen Methods., 32, 816-8
- D Nantakomol, 2013, Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency., Malar J., 12, 289, 10.1186/1475-2875-12-289 · DOI
- N Oo, 2016, Validation of G6PD point-of-care tests among healthy volunteers in Yangon, Myanmar., PLoS One., 11, e0152304, 10.1371/journal.pone.0152304 · DOI · Paper page
- G Bancone, 2015, Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests., Am J Trop Med Hyg., 92, 818-24, 10.4269/ajtmh.14-0696 · DOI · Paper page
- A Roca-Feltrer, 2014, Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia., PLoS One., 9, e116143, 10.1371/journal.pone.0116143 · DOI · Paper page
- G Bancone, 2017, Prevalences of inherited red blood cell disorders in pregnant women of different ethnicities living along the Thailand-Myanmar border [version 2; referees: 2 approved]., Wellcome Open Res., 2, 72, 10.12688/wellcomeopenres.12338.2 · DOI · Paper page
- S AlSaif, 2017, Screening for glucose-6-phosphate dehydrogenase deficiency in neonates: a comparison between cord and peripheral blood samples., BMC Pediatr., 17, 159, 10.1186/s12887-017-0912-y · DOI
- S Travis, 1980, Red cell metabolic alterations in postnatal life in term infants: glycolytic enzymes and glucose-6-phosphate dehydrogenase., Pediatr Res., 14, 1349-52, 10.1203/00006450-198012000-00016 · doi:10.1203/00006450-198012000-00016
- M Kaplan, 2005, Glucose-6-phosphate dehydrogenase activity in term and near-term, male African American neonates., Clin Chim Acta., 355, 113-7, 10.1016/j.cccn.2004.12.008 · doi:10.1016/j.cccn.2004.12.008
- N Cohan, 2010, The efficacy of a neonatal screening programme in decreasing the hospitalization rate of patients with G6PD deficiency in southern Iran., J Med Screen., 17, 66-7, 10.1258/jms.2010.009105 · DOI
- M Kosaryan, 2014, Why does the Iranian national program of screening newborns for G6PD enzyme deficiency miss a large number of affected infants?, Pediatr Hematol Oncol., 31, 95-100, 10.3109/08880018.2013.871613 · DOI
- L Thielemans, 2017, Neonatal Hyperbilirubinemia in a Marginalized Population on the Thai-Myanmar Border: a study protocol., BMC Pediatr., 17, 32, 10.1186/s12887-017-0798-8 · DOI
- K Plewes, 2017, Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria., Malar J., 16, 134, 10.1186/s12936-017-1788-x · DOI
- M Kosaryan, 2014, Why does the Iranian national program of screening newborns for G6PD enzyme deficiency miss a large number of affected infants?, Pediatr Hematol Oncol., 31, 95-100, 10.3109/08880018.2013.871613 · DOI
- J Jiang, 2014, Screening and prevention of neonatal glucose 6-phosphate dehydrogenase deficiency in Guangzhou, China., Genet Mol Res., 13, 4272-9, 10.4238/2014.June.9.13 · doi:10.4238/2014.june.9.13
- M Lakomek, 1989, On the diagnosis of erythrocyte enzyme defects in the presence of high reticulocyte counts., Br J Haematol., 72, 445-51, 10.1111/j.1365-2141.1989.tb07730.x · doi:10.1111/j.1365-2141.1989.tb07730.x
- R Christensen, 2016, Reference intervals for reticulocyte parameters of infants during their first 90 days after birth., J Perinatol., 36, 61-6, 10.1038/jp.2015.140 · doi:10.1038/jp.2015.140
- G Paterakis, 1993, Flow-cytometric analysis of reticulocytes in normal cord blood., Acta Haematol., 90, 182-5, 10.1159/000204454 · DOI · Paper page
- M Kaplan, 2015, Parental education and the WHO neonatal G-6-PD screening program: a quarter century later., J Perinatol., 35, 779-84, 10.1038/jp.2015.77 · DOI
- F Keihanian, 2017, Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period., Int J Lab Hematol., 39, 251-60, 10.1111/ijlh.12618 · DOI
- N Algur, 2012, Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype., J Pediatr., 161, 197-200, 10.1016/j.jpeds.2012.02.045 · DOI
- M De Niz, 2013, Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda., Malar J., 12, 210, 10.1186/1475-2875-12-210 · DOI
- V Bhutani, 2015, Point-of-Care Quantitative Measure of Glucose-6-Phosphate Dehydrogenase Enzyme Deficiency., Pediatrics., 136, e1268-75, 10.1542/peds.2015-2122 · DOI
- B Ley, 2017, Methods for the field evaluation of quantitative G6PD diagnostics: a review., Malar J., 16, 361, 10.1186/s12936-017-2017-3 · DOI · Paper page
Cited by
Bancone, G., Gornsawun, G., Chu, C. S., Porn, P., Pal, S., Bansil, P., Domingo, G. J., & Nosten, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196716 · Cited by 65
Self-citationThielemans, L., Peerawaranun, P., Mukaka, M., Paw, M. K., Wiladphaingern, J., Landier, J., Bancone, G., Proux, S., Elsinga, H., Trip-Hoving, M., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0258127 · Cited by 20
Self-citationBancone, G., Gornsawun, G., Peerawaranun, P., Penpitchaporn, P., Paw, M. K., Poe, D. D., Win, D., Cicelia, N., Mukaka, M., Archasuksan, L., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000475 · Cited by 14
“7% of deficient newborns missed) and cannot identify females with intermediate phenotypes [28].”
BackgroundSelf-citationUrban malaria in Accra, Ghana: transmission risk and influence of irrigated vegetable farms
Sabtiu, A. R. M., Sraku, I. K., Owusu-Asenso, C. M., Akuamoah-Boateng, Y., Doe, R. T., Boadu, E. N., Azumah, J. D., Eyeson, N. A. S., Abdulai, A., Amoateng, G., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11403-6 · Cited by 13
Cohort Profile: the SMRU Refugee and Migrant Pregnancy Study in Western Thailand and Eastern Myanmar
McGready, R., J White, N., Nosten, F. H., & Collaborators, S. R. A. M. P. S. (2026) · Wellcome Open Research · doi:10.12688/wellcomeopenres.25582.2 · Cited by 2
Self-citation
Metadata
- Authors
- Thielemans, L., Gornsawun, G., Hanboonkunupakarn, B., Paw, M. K., Porn, P., Moo, P. K., Van Overmeire, B., Proux, S., Nosten, F., McGready, R., Carrara, V. I., & Bancone, G.
- Venue
- Wellcome Open Research
- Publisher
- F1000 Research Ltd
- Published
- 2018-01-02
- Volume
- 3
- Pages
- 1
- ISSN
- 2398-502X (ISSN-L)
- OpenAlex
- W2781635256
- Cited by
- 49
- References
- 5
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- Wellcome Trust (089179, 106698)
- The Belgian Kids' Fund for Pediatric Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.